These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 16627812)
1. T cell costimulation in the development of cardiac allograft vasculopathy: potential targets for therapeutic interventions. Isobe M; Kosuge H; Suzuki J Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1447-56. PubMed ID: 16627812 [TBL] [Abstract][Full Text] [Related]
2. Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation. Sánchez Lázaro IJ; Almenar Bonet L; Moro López J; Sánchez Lacuesta E; Martínez-Dolz L; Agüero Ramón-Llín J; Andrés Lalaguna L; Cano Pérez O; Ortiz Martínez V; Buendía Fuentes F; Salvador Sanz A Transplant Proc; 2008 Nov; 40(9):3056-7. PubMed ID: 19010192 [TBL] [Abstract][Full Text] [Related]
3. Cardiac allograft vasculopathy: current knowledge and future direction. Colvin-Adams M; Agnihotri A Clin Transplant; 2011; 25(2):175-84. PubMed ID: 21457328 [TBL] [Abstract][Full Text] [Related]
4. Treatment and prophylaxis of cardiac allograft vasculopathy. Wang SS Transplant Proc; 2008 Oct; 40(8):2609-10. PubMed ID: 18929815 [TBL] [Abstract][Full Text] [Related]
5. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response. van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796 [TBL] [Abstract][Full Text] [Related]
7. Cardiac allograft vasculopathy: central role of endothelial injury leading to transplant "atheroma". Valantine HA Transplantation; 2003 Sep; 76(6):891-9. PubMed ID: 14508350 [TBL] [Abstract][Full Text] [Related]
9. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy. Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806 [TBL] [Abstract][Full Text] [Related]
10. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy. Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667 [TBL] [Abstract][Full Text] [Related]
12. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy. Soleimani B; Fu F; Lake P; Shi VC J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883 [TBL] [Abstract][Full Text] [Related]
13. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. Jonas M; Fang JC; Wang JC; Giri S; Elian D; Har-Zahav Y; Ly H; Seifert PA; Popma JJ; Rogers C J Am Coll Cardiol; 2006 Aug; 48(3):453-61. PubMed ID: 16875968 [TBL] [Abstract][Full Text] [Related]
14. Intimal fibrosis in human cardiac allograft vasculopathy. Huibers M; De Jonge N; Van Kuik J; Koning ES; Van Wichen D; Dullens H; Schipper M; De Weger R Transpl Immunol; 2011 Sep; 25(2-3):124-32. PubMed ID: 21782945 [TBL] [Abstract][Full Text] [Related]
18. The influence of cytomegalovirus infection, confirmed by pp65 antigen presence, on the development of cardiac allograft vasculopathy. Zakliczyński M; Krynicka-Mazurek A; Pyka Ł; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M Transplant Proc; 2007 Nov; 39(9):2866-9. PubMed ID: 18022004 [TBL] [Abstract][Full Text] [Related]
19. Transplant vascular disease: role of lipids and proteoglycans. Rahmani M; McDonald PC; Wong BW; McManus BM Can J Cardiol; 2004 Aug; 20 Suppl B():58B-65B. PubMed ID: 15309207 [TBL] [Abstract][Full Text] [Related]
20. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy? Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]